Glikopironium bromida: Perbedaan antara revisi

Konten dihapus Konten ditambahkan
Muhammad Anas Sidik (bicara | kontrib)
←Membuat halaman berisi '{{Infobox drug | image = Glycopyrronium bromide.svg | Verifiedfields = changed | INN = Glycopyrronium | verifiedrevid = 461122867 | width = | alt = | caption = | USAN = glycopyrrolate <!-- Clinical data -->| pronounce = | tradename = Robinul, Cuvposa, Seebri, dll | Drugs.com = {{drugs.com|monograph|glycopyrrolate}} | MedlinePlus = a602014 | DailyMedID = Glycopyrrolate | pregnancy_AU = B2 | pregnancy_AU_comment = | pregnancy_category = | routes_of_administr...'
Tag: halaman dengan galat kutipan tanpa kategori [ * ] Suntingan perangkat seluler Suntingan peramban seluler Suntingan seluler lanjutan
 
Muhammad Anas Sidik (bicara | kontrib)
Tidak ada ringkasan suntingan
Tag: halaman dengan galat kutipan Suntingan perangkat seluler Suntingan peramban seluler Suntingan seluler lanjutan
Baris 107:
 
Pada bulan September 2012, glikopironium disetujui untuk penggunaan medis di [[Uni Eropa]].<ref name="Seebri Breezhaler EPAR" /> Pada bulan Juni 2018, glikopironium disetujui oleh [[Badan Pengawas Obat dan Makanan Amerika Serikat]] (FDA) untuk mengobati keringat berlebih pada ketiak, sehingga menjadikannya obat pertama yang dikembangkan secara khusus untuk mengurangi keringat berlebih.<ref>{{Cite news|url=https://apnews.com/21f28f1327ca4f9497cf878cc0229444|title=FDA OKs first drug made to reduce excessive sweating|work=AP News|access-date=2018-07-02|archive-date=2018-07-02|archive-url=https://web.archive.org/web/20180702233319/https://apnews.com/21f28f1327ca4f9497cf878cc0229444|url-status=live}}</ref> Obat ini masuk dalam [[Daftar Obat Esensial Organisasi Kesehatan Dunia]].<ref name="WHO22nd">{{cite book | vauthors = ((World Health Organization)) | title = World Health Organization model list of essential medicines: 22nd list (2021) | year = 2021 | hdl = 10665/345533 | author-link = World Health Organization | publisher = World Health Organization | location = Geneva | id = WHO/MHP/HPS/EML/2021.02 | hdl-access=free }}</ref>
==Kegunaan dalam medis==
==Efek samping==
==Farmakologi==
==Penelitian==
==Referensi==
{{reflist}}
{{Portal bar | Medicine}}
[[Category:Carboxylate esters]]
[[Category:M1 receptor antagonists]]
[[Category:M2 receptor antagonists]]
[[Category:M3 receptor antagonists]]
[[Category:M4 receptor antagonists]]
[[Category:M5 receptor antagonists]]
[[Category:Peripherally selective drugs]]
[[Category:Phenylcyclopentylglycolate esters]]
[[Category:Quaternary ammonium compounds]]
[[Category:Pyrrolidines]]
[[Category:Tertiary alcohols]]